MAPT and early-onset autosomal dominant Alzheimer disease: <h4>Importance</h4>With blood-based phosphorylated tau biomarkers soon to be used for diagnosis of Alzheimer disease, analyzing tau levels in other conditions could enhance biomarker interpretability.